In the vast and highly specialized biotechnology sector, where scientific innovation results in long, expensive, and often uncertain development paths, the value of enterprises does not come from current revenues, but from the quality of the research portfolio, the soundness of patents, and the likelihood of clinicalUnbiased Alpha is a Swiss Fintech startup consulting institutional investors across the globe in Quantitative Trading and Systematic Strategies. The company develops software solutions, cloud se ...